Elevated Serum Levels of Interferon‐γ–Inducible Protein–10 in Patients Coinfected with Hepatitis C Virus and HIV
1Centre for Research in Infectious Diseases and 2National Virus Reference Laboratory, School of Medicine and Medical Sciences, University College Dublin, and 3Department of Genitourinary Medicine and Infectious Diseases and 4Hepatology Centre, St. James’s Hospital, Dublin, Ireland
Coinfection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) is associated with an accelerated course of HCV infection and a faster progression to severe liver disease. We have investigated whether the development of liver disease in coinfected patients is associated with specific chemokine and cytokine production. Four cohorts—HCV/HIV‐coinfected patients, HCV‐monoinfected patients, HIV‐monoinfected patients, and healthy control subjects—were studied. Serum levels of the 10‐kDa interferon‐γ–inducible protein (IP‐10) were higher in all 3 groups of infected patients than in control subjects (
). HCV/HIV‐coinfected patients had significantly higher IP‐10 levels than monoinfected patients. In HCV‐monoinfected patients, liver fibrosis scores and liver enzyme levels were positively correlated with IP‐10 levels. Elevated IP‐10 levels are associated with and may contribute to liver damage in both HCV‐monoinfected and HCV/HIV‐coinfected patients.
Received 29 January 2007; accepted 8 April 2007; electronically published 21 August 2007.
Cited by
Online publication date: 1-Sep-2009.
CrossRef
Online publication date: 1-Apr-2009.
Online publication date: 1-Nov-2008.
CrossRef
Online publication date: 1-Aug-2008.
CrossRef
-
Potential conflicts of interest: none reported.
Financial support: National Virus Reference Laboratory, University College Dublin, Ireland (grant 8090).





